Nonhuman primate models of encephalitic alphavirus infection: Historical review and future perspectives

Current Opinion in Virology

Volumn 2, Issue 3, 2012, Pages 363-367

  Dupuy, Lesley C ^a   Reed, Douglas S ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVIRUS VACCINE; DNA VACCINE; UNCLASSIFIED DRUG; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS VACCINE; VIRUS VACCINE;

ALPHAVIRUS INFECTION; DRUG EFFICACY; EASTERN EQUINE ENCEPHALITIS; ENCEPHALITIC ALPHAVIRUS INFECTION; FATALITY; FEVER; IN VIVO STUDY; LEUKOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS INFECTION; VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS INFECTION; VIREMIA; VIRUS ENCEPHALITIS; VIRUS PATHOGENESIS; WESTERN EQUINE ENCEPHALITIS;

ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DRUG APPROVAL; ENCEPHALITIS, VIRAL; HUMANS; PRIMATES; VIRAL VACCINES;

EID: 84862853951     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.02.014     Document Type: Review

References (32)

1. Griffin DE: Alphaviruses. In Fields Virology, vol 4. Edited by Knipe D, Howley PM. Lippincott, Williams, and Wilkins; 2001:917-962.
2. Tsai TF: Arboviral infections in the United States. Infect Dis Clin North Am 1991, 5:73-102.
3. Bale JF Jr: Viral encephalitis. Med Clin North Am 1993, 77:25-42.
4. Steele K, Reed DS, Glass PJ, Hart MK, Ludwig GV, Pratt WD, Parker MD, Smith JF: Alphavirus encephalitides. In Medical Aspects of Biological Warfare. Edited by Dembek ZF. Borden Institute (U.S. Army Walter Reed); 2007:241-270.
5. Pittman PR, Makuch RS, Mangiafico JA, Cannon TL, Gibbs PH, Peters CJ: Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 1996, 14:337-343. (Pubitemid 26126438)
6. McKinney RW, Berge TO, Sawyer WD, Tigertt WD, Crozier D: Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man. Am J Trop Med Hyg 1963, 12:597-603.
7. Cole FE Jr, May SW, Robinson DM: Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells. Appl Microbiol 1973, 25:262-265.
8. Jahrling PB, Stephenson EH: Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol 1984, 19:429-431. (Pubitemid 14187604)
9. Paessler S, Weaver SC: Vaccines for Venezuelan equine encephalitis. Vaccine 2009, 27(Suppl. 4):D80-D85.
10. Gleiser CA, Gochenour WS Jr, Berge TO, Tigertt WD: Studies on the virus of Venezuelan equine encephalomyelitis. I. Modification by cortisone of the response of the central nervous system of Macaca mulatta. J Immunol 1961, 87:504-508. Comprehensive early study examining the pathogenesis of VEEV infection in NHPs.
11. Steele KE, Twenhafel NA: REVIEW PAPER: pathology of animal models of Alphavirus encephalitis. Vet Pathol 2010, 47:790-805.
12. Verlinde JD: Susceptibility of cynomolgus monkeys to experimental infection with arboviruses of group A (Mayaro and Mucambo), group C (Oriboca and Restan) and an unidentified arbovirus (Kwatta) originating from Surinam. Trop Geogr Med 1968, 20:385-390. Demonstration of effect of route of inoculation on VEEV pathogenesis in NHPs.
13. Monath TP, Calisher CH, Davis M, Bowen GS, White J: Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus. J Infect Dis 1974, 129:194-200. Comparison of infection of NHPs with epizootic and enzootic subtypes of VEEV.
14. Danes L, Kufner J, Hruskova J, Rychterova V: The role of the olfactory route on infection of the respiratory tract with Venezuelan equine encephalomyelitis virus in normal and operated Macaca rhesus monkeys. I. Results of virological examination. Acta Virol 1973, 17:50-56. Demonstration of the role of the olfactory nerve in IN infection of NHPs with VEEV.
15. Danes L, Rychterova V, Kufner J, Hruskova J: The role of the olfactory route on infection of the respiratory tract with Venezuelan equine encephalomyelitis virus in normal and operated Macaca rhesus monkeys. II. Results of histological examination. Acta Virol 1973, 17:57-60. Demonstration of the role of the olfactory nerve in IN infection of NHPs with VEEV.
16. Pratt WD, Gibbs P, Pitt ML, Schmaljohn AL: Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. Vaccine 1998, 16:1056-1064. Development of an aerosol challenge model of VEEV infection of NHPs with refinement by the use of telemetry to measure febrile responses. (Pubitemid 28276023)
17. Pratt WD, Davis NL, Johnston RE, Smith JF: Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine 2003, 21:3854-3862. (Pubitemid 37345132)
18. Reed DS, Lind CM, Lackemeyer MG, Sullivan LJ, Pratt WD, Parker MD: Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 2005, 23:3139-3147.
19. Fine DL, Roberts BA, Terpening SJ, Mott J, Vasconcelos D, House RV: Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Vaccine 2008, 26:3497-3506.
20. Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS: A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clin Vaccine Immunol 2011, 18:707-716.
21. Dupuy LC, Richards MJ, Reed DS, Schmaljohn CS: Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. Vaccine 2010, 28:7345-7350.
22. Muehlenbein MP, Cogswell FB, James MA, Koterski J, Ludwig GV: Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques. Virol J 2006, 3:19.
23. Hammamieh R, Barmada M, Ludwig G, Peel S, Koterski N, Jett M: Blood genomic profiles of exposures to Venezuelan equine encephalitis in cynomolgus macaques (Macaca fascicularis). Virol J 2007, 4:82.
24. Koterski J, Twenhafel N, Porter A, Reed DS, Martino-Catt S, Sobral B, Crasta O, Downey T, DaSilva L: Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus. FEMS Immunol Med Microbiol 2007, 51:462-472. (Pubitemid 350076156)
25. Reed DS, Lind CM, Sullivan LJ, Pratt WD, Parker MD: Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses. J Infect Dis 2004, 189:1013-1017. (Pubitemid 38373093)
26. Howitt BF: Equine encephalomyelitis. J Infect Dis 1932, 51:493-510.
27. Hurst EW: Infection of the rhesus monkey (Macaca mulatta) and the guinea-pig with the virus of equine encephalomyelitis. J Pathol Bacteriol 1936, 42:271-302.
28. Wyckoff RWG, Tesar WC: Equine encephalitis in monkeys. J Immunol 1939, 37:329-343.
29. Reed DS, Larsen T, Sullivan LJ, Lind CM, Lackemeyer MG, Pratt WD, Parker MD: Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J Infect Dis 2005, 192:1173-1182. Development of an aerosol challenge model of WEEV infection of NHPs. (Pubitemid 41368416)
30. Reed DS, Lackemeyer MG, Garza NL, Norris S, Gamble S, Sullivan LJ, Lind CM, Raymond JL: Severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus. J Infect Dis 2007, 196:441-450. Development of an aerosol challenge model of EEEV infection of NHPs. (Pubitemid 47093895)
31. Espinosa BJ, Weaver SC, Paessler S, Brining D, Salazar M, Kochel T: Susceptibility of the Aotus nancymaae owl monkey to eastern equine encephalitis. Vaccine 2009, 27:1729-1734.
32. Adams AP, Aronson JF, Tardif SD, Patterson JL, Brasky KM, Geiger R, de la Garza M, Carrion R Jr, Weaver SC: Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol 2008, 82:9035-9042. Use of marmosets as an alternative NHP model of EEEV infection.